What is NeuroPace Inc (NPCE)?
NeuroPace Inc is a medical device company specializing in the development of implantable neurostimulation systems for the treatment of neurological disorders. The company’s primary focus is on devices designed to monitor and respond to abnormal brain activity, particularly in patients with epilepsy. NeuroPace Inc’s technology involves responsive neurostimulation that detects seizure activity and delivers targeted electrical stimulation to disrupt it, aiming to reduce the frequency and severity of seizures. The company’s products are intended for patients who are resistant to conventional therapies and seek alternative treatment options. NeuroPace Inc operates within the medical technology and healthcare sectors, contributing to advancements in neuromodulation and personalized medicine. Its research and development efforts focus on improving device efficacy, patient safety, and quality of life for individuals with neurological conditions.
NeuroPace Inc Stock Price Today: Live Overview
The price today is shaped by active trading as NeuroPace Inc stands at $13.67. During the session, the price ranged from $13.1 to $13.37, showing a daily change of +0.7547%.
FAQ: NeuroPace Inc (NPCE)
What is the current price of NPCE stock?
NeuroPace Inc's current price is $13.67.
Does NPCE pay dividends?
The company does not pay dividends.
Does NPCE have a formal corporate presence or regional headquarters in the UAE?
NeuroPace Inc operates through partners in the UAE without an official regional office or subsidiary.
What is NPCE best known for?
The company is most famous for its responsive neurostimulation system for epilepsy treatment.
What assets are typically shown together with NPCE?
Commonly shown alongside NPCE: FW Thorpe PLC, Flowserve, Arafura Rare Earths LTD
Latest shares articles



